Medication info

Cotention Tablet 5/100mg

Prescription medicationApproval withdrawn
Ingredient · strength
Amlodipine Besylate›Strength being verifiedLosartan Potassium›Strength being verified
Manufacturer / importer
JW Pharmaceutical Co., Ltd.
Appearance
Pale pink rectangular film-coated tablets
Packaging
30 tablets / bottle
Approval status
Approval withdrawn

MFDS item code 201502708 · Approved 2015.04.30

This product's status changed to Approval withdrawn on 2023.06.02. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy and Stage II hypertension requiring initial combination therapy
Who uses it
Adults · Children
Adult dosage
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual ingredients (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual ingredients as described below, switching directly to this medicine may be considered. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected extent to which the treatment target will be achieved with the combination product compared with monotherapy. The usual dose is 5/50 mg once daily; if blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced effective intravascular volume: Administration of this medicine is not recommended in a small number of patients with reduced effective intravascular volume (e.g., patients receiving treatment with high-dose diuretics). (See Section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: Since a starting dose of losartan of 25 mg once daily is recommended for older adults aged 75 years or older, use of this medicine as initial therapy is not recommended.
Children's dosage
The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; its use is not recommended.

Ingredients

Manufacturer
JW Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy and Stage II hypertension requiring initial combination therapy

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with amlodipine or losartan. It is also applicable as initial therapy when combination therapy is required to achieve target blood pressure in patients with stage 2 hypertension. Therefore, it is effectively used in managing hypertension that is difficult to control.

Dosage and Administration

Adult dosage

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual ingredients (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual ingredients as described below, switching directly to this medicine may be considered. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected extent to which the treatment target will be achieved with the combination product compared with monotherapy. The usual dose is 5/50 mg once daily; if blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced effective intravascular volume: Administration of this medicine is not recommended in a small number of patients with reduced effective intravascular volume (e.g., patients receiving treatment with high-dose diuretics). (See Section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: Since a starting dose of losartan of 25 mg once daily is recommended for older adults aged 75 years or older, use of this medicine as initial therapy is not recommended.

Children's dosage

The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; its use is not recommended.

Precautions

This drug can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters. If pregnancy is confirmed, discontinuation should occur immediately, and it is safer not to use this drug during pregnancy. Caution is necessary for patients with reduced blood volume or those on diuretics, as hypotensive symptoms may appear when starting this medication. Use should be avoided in patients with allergies to the active ingredients or similar medications. Patients with severe liver or kidney dysfunction, significant aortic stenosis, or in a state of shock should also avoid this medication. Blood pressure may drop suddenly, so activities involving high-risk machine operations, such as working at heights or driving, should be avoided. This drug may have an enhanced effect when used with other antihypertensives, thus it should be taken cautiously under the guidance of a professional. Co-administration with grapefruit juice may potentiate the drug's effect, so it should be avoided. Women who are pregnant or breastfeeding should not take this medication, especially during lactation, as it may pass into breast milk. Safety and efficacy have not been established for children and adolescents under 18 years old, so its use is not recommended. In elderly patients, particularly those over 75 years old, initial dosage adjustments may be necessary, and this combination drug may not be appropriate. Overdosage can lead to severe hypotension or heart problems, so caution is essential, and immediate treatment is required in emergencies. This medication should be kept out of reach of children, and transferring it to other containers should be avoided to maintain quality.

Side effects

  • Hypotension
  • neonatal skull formation deficiency
  • anuria
  • renal failure
  • oligohydramnios
  • fetal limb hypoplasia
  • craniofacial deformities
  • pulmonary hypoplasia
  • immature
  • intrauterine growth retardation
Show 207 more
  • patent ductus arteriosus
  • dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pitting edema
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux disease
  • constipation
  • itching
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • conjunctival injection
  • polyuria
  • fatigue
  • edema
  • vertigo
  • abdominal pain
  • nausea
  • weakness
  • lethargy
  • pain
  • weight gain
  • weight loss
  • hypotension
  • vasculitis
  • tension increase
  • sensory loss
  • paresthesia
  • peripheral neuropathy
  • syncope
  • taste disturbances
  • tremor
  • erectile dysfunction
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • gingival hypertrophy
  • pancreatitis
  • vomiting
  • hyperglycemia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • cough
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • urinary disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • hypotension
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • cutaneous flushing
  • maculopapular rash
  • heaviness
  • warmth
  • impaired glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • lower limb pain
  • congestion
  • upper respiratory tract infection
  • sinusitis
  • diarrhea
  • sinus dysfunction
  • pharyngitis
  • myalgia
  • insomnia
  • swelling
  • abdominal pain
  • angioedema
  • skin sloughing phenomenon
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • hypotension
  • myocardial infarction
  • atrial fibrillation
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • muscle weakness
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory reduction
  • decreased libido
  • memory impairment
  • migraine
  • neuroasthenia
  • panic disorder
  • sleep disorders
  • tremor
  • bronchitis
  • pharyngeal discomfort
  • nasal bleeding
  • rhinitis
  • respiratory congestion
  • hair loss
  • dermatitis
  • dry skin
  • petechial hemorrhage
  • erythema
  • photosensitivity
  • itching
  • rash
  • sweating
  • urticaria
  • blurred vision
  • burning sensation and pain in the eyes
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • decreased vision
  • erectile dysfunction
  • nocturia
  • urethral infection
  • dry cough
  • angioedema
  • vasculitis
  • anaphylactic reaction
  • hepatitis
  • liver dysfunction
  • lethargy
  • thrombocytopenia
  • rhabdomyolysis
  • dysgeusia
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • ALT elevation
  • serum creatinine elevation
  • elevated liver enzymes
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactoid syndrome
  • excessive peripheral vasodilation
  • reflex tachycardia
  • systemic hypotension
  • shock
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. Such storage will help preserve the drug’s efficacy and prevent deterioration.

Appearance and packaging

Appearance

Pale pink rectangular film-coated tablets

Package unit

30 tablets / bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.